Latest Articles
Brad McCarty • March 26, 2019

The American College of Cardiology’s Scientific Session is an annual event that draws physicians, vendors, startups, and subject matter experts from across the United States. For the past two years, AngelMD has had the privilege of hosting the ACC’s Innovation Challenge. The Innovation Challenge pits a pool of startup contestants against one another in a ...
Read more

LinkedInTwitterFacebook
Michael Raymer • March 13, 2019

This is the second in a series of articles where we examine the macro-level trends that support the thesis of our business. The wisdom of crowds is a well-studied business phenomenon chronicled in a book by James Surowiecki. He makes the case that, under the right circumstances, groups are remarkably intelligent and outperform the smartest ...
Read more

LinkedInTwitterFacebook
Brad McCarty • March 5, 2019

The ultimate goal of AngelMD is to facilitate improved outcomes for startups, investors, and ultimately for patients. Today we are proud to share the news that Saranas, an AngelMD portfolio company, has obtained FDA clearance for its Early Bird Bleed Monitoring system.  A recent study of over 17,000 large-bore transcatheter interventions showed that nearly one ...
Read more

LinkedInTwitterFacebook